BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

3 Apr 2018

The company’s environmental efforts honored for the fourth consecutive year.

The US Environmental Protection Agency (EPA) and the US Department of Energy have recognized Bristol-Myers Squibb (BMS) with an ENERGY STAR Partner of the Year Sustained Excellence Award for outstanding efforts to improve the energy efficiency of facilities worldwide. BMS has earned the ENERGY STAR Partner of the Year award for the past 4 consecutive years.

BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

The award confirms BMS’s long-term commitment to environmental responsibility through driving sustainable improvements in energy with a goal of reducing the company use or resources across its drug discovery, development and delivery pipeline.

“We are proud to receive the ENERGY STAR Partner of the Year designation for 4 years, and to increase our recognition with the Sustained Excellence Award,” said Carol Ryerkerk Powell, vice president of Environment, Health, Safety and Sustainability, BMS. “To continue developing innovative medicines for our patients, we have to embrace our responsibility to support our environment, employees and communities. We look forward to our continued partnership with ENERGY STAR to better advance our energy management programs and demonstrate our leadership within the pharmaceutical industry.”

BMS was recognized for the following accomplishments:
  • Achieving an annual energy intensity improvement of more than $% globally, contributing to an 11.3% reduction in energy consumption since 2013.
  • Assisting the ENERGY STAR program with energy treasure hunt training for healthcare energy managers and conducting a treasure hunt with an external organization, St Joseph’s Medical Center in Bloomington, Illinois.
  • Achieving the ENERGY STAR Challenge for Industry at two sites and taking the challenge at eight new sites.
  • Hosting the first ENERGY STAR showcase event at a pharmaceutical facility that engaged employees, local government officials and ENERGY STAR industrial partners.
  • Earning ENERGY STAR certification at two office buildings.
  • Actively participating in the ENERGY STAR Focus on Energy Efficiency in Pharmaceutical Manufacturing and the ENERGY STAR industrial partnership.
  • Investing over $42.4 million across 342 energy projects to achieve an annualized savings of over $18.3 million since 2010.
  • In addition to the company’s recognition as an ENERGY STAR Partner of the Year, BMS’s R&D site in Hopewell, New Jersey, and the manufacturing site in New Brunswick, New Jersey earned the 2017 Challenge for Industry recognition. The ENERGY STAR Challenge for Industry is a national call-to-action to improve energy efficiency of America’s manufacturers by 10% or more. By taking the ENERGY STAR Challenge, sites set a goal to reduce their energy intensity by 10% within 5 years.

    Read More

    Related tags

    Market News

    Related news

    Spanish CDMO working ahead of EU serialisation deadline

    Spanish CDMO working ahead of EU serialisation deadline

    6 Dec 2018

    Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner.

    Read more 
    Fluidic Analytics raises $31m to launch new lab tools and unlock biology behind major diseases

    Fluidic Analytics raises $31m to launch new lab tools and unlock biology behind major diseases

    5 Dec 2018

    The financing will power the global commercial launch of the company's Fluidity One system.

    Read more 
    OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

    OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

    4 Dec 2018

    The new treatment will leverage OnDosis’ proprietary technology, which integrates oral drugs in form of micro units and individualised dosing, in a handheld device.

    Read more 
    India to have strongest global growth in 2019?

    India to have strongest global growth in 2019?

    4 Dec 2018

    Main drivers cited as ‘high-growth domestic market’ and ‘expanding manufacturing exports’.

    Read more 
    Catalent to expand biologics packaging capabilities

    Catalent to expand biologics packaging capabilities

    3 Dec 2018

    Company's $14 million investment follows twentieth commercial drug approval at Bloomington, Indiana site.

    Read more 
    Merck successfully divests Consumer Health

    Merck successfully divests Consumer Health

    2 Dec 2018

    Closing of sale to Procter & Gamble at a cash purchase price of €3.4 billion completed.

    Read more 
    Digital manufacturing is a top priority for life sciences

    Digital manufacturing is a top priority for life sciences

    29 Nov 2018

    Zenith Technology survey reveals that more than half of those surveyed believe that Industry 4.0 will drive the most change.

    Read more 
    NIH to evaluate effectiveness of male contraceptive skin gel

    NIH to evaluate effectiveness of male contraceptive skin gel

    28 Nov 2018

    The gel formulation includes the progestin compound segesterone acetate, in combination with testosterone, and is applied to the back and shoulders and absorbed through the skin.

    Read more 
    QPS expands US-based Phase I clinical trial capabilities

    QPS expands US-based Phase I clinical trial capabilities

    27 Nov 2018

    Expansion supports the growing needs of the company's pharmaceutical, biotechnology and CRO partners.

    Read more 
    Hikma announces injectable licensing agreement

    Hikma announces injectable licensing agreement

    27 Nov 2018

    Company provided with exclusive rights to market a suite of Hansoh's injectable oncology medicines within the US for the next 5 years.

    Read more